References
- Belpaire F., Vanderheeren F., Bogaert M. Binding of thioridazine and some of its metabolites to human serum protein and human albumin. Arzneim-Forschung. 1975; 25: 1969–1971
- Boyd A., Reichlin S. Neural control of prolactin secretion in man. Psychoneuroendocrinology 1978; 3: 113–130
- Creese I., Burt D., Snyder S. Dopamine receptor binder predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192: 481–483
- De Rivera J., Lal S., Ettigi P., Hontela S., Muller H., Friesen H. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clinical Endocrinology 1976; 5: 273–282
- Donoso A., Bishop W., Fawcett C., Krulich L., McCann S. Effects of drugs that modify brain monoamine concentrations on plasma gonadotrophin and prolactin levels in the rat. Endocrinology 1971; 89: 774–784
- Gruen P., Sachar E., Altman N., Langer G., Tabrizi M., Halpern F. Relation of plasma prolactin to clinical response in schizophrenic patients. Archives of General Psychiatry 1978; 35: 1222–1227
- Langer G., Sachar E. Dopaminergic factors in human prolactin regulation: effects of neuroleptics and dopamine. Psychoneuroendocrinology 1977; 2: 373–378
- Langer G., Sachar E., Gruen P., Halpern F. Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency. Nature 1977; 266: 639–640
- Malarkey W., Jacobs L., Daughaday W. Levodopa suppression of prolactin in non-puerperal galactorrohoea. New England Journal of Medicine 1971; 285: 1160–1163
- Meltzer H., Fang V. The effect of neuroleptics on serum prolactin in schizophrenic patients. Archives of General Psychiatry 1976; 33: 279–286
- Meltzer H., Fang V., Goode D. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man. Psychopharmacology Bulletin 1978; 14: 5–7
- Meltzer H., Sachar E., Frantz A. Serum prolactin levels in unmedicated schizophrenic patients. Archives of General Psychiatry 1974; 31: 564–569
- Nikitopoulou G., Thorner M., Crammer J., Lader M. Prolactin and psychophysiologic measures after single doses of thioridazine. Clinical Pharmacology and Therapeutics 1977; 21: 422–429
- Ohman R., Axelsson R. Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patients. European Journal of Clinical Pharmacology 1978; 14: 111–116
- Rubin R., Hays S. Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men. Psychopharmacology 1979; 61: 17–24
- Sakalis G., Traficante L., Gershon S. Thioridazine metabolism and clinical response: a pilot study. Current Therapeutic Research 1977; 21: 720–724
- Siris S., Van Kammen D., de Fraites E. Serum prolactin and antipsychotic responses to pimozide in schizophrenia. Psychopharmacology Bulletin 1978; 14: 11–14
- Vanderheeren F., Muusze R. Plasma levels and half lives of thioridazine and some of its metabolites. European Journal of Clinical Pharmacology 1977; 11: 135–140
- Wilson R., Hamilton J., Boyd W., Forrest A., Cole E., Boyns A., Griffiths K. The effect of long term phenothiazine therapy on plasma prolactin. British Journal of Psychiatry 1975; 127: 71–74